# A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects

> **NCT00162045** · PHASE1,PHASE2 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 79 (actual)

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** Technetium Tc99m Sestamibi

## Key facts

- **NCT ID:** NCT00162045
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-05
- **Final completion:** 2007-06
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2011-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162045, "A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00162045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*